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Abstract
Background: Hepatitis E virus (HEV) is a pathogen of emerging concern in industrialized countries. The
consumption of wild boar meat has been identified as one risk factor for autochthonous HEV infections. Only
limited information is available about thermal stability of HEV, mainly due to the lack of rapid and efficient cell
culture systems for measurement of HEV infectivity.
Methods: A molecular biological method was implemented in order to distinguish disassembled from intact viral
particles using RNase treatment followed by quantitative real-time RT-PCR. The method was applied to a wild boar
liver suspension containing HEV genotype 3.
Results: Time-course analyses indicated that the decline of protected RNA could be described by a biphasic model
with an initial decrease followed by a stationary phase. The stationary phase was reached after 1 hour at 4°C, 3
days at 22°C and 7 days at 37°C with log reductions of 0.34, 0.45 and 1.24, respectively. Protected RNA was
detectable until the end of the experiments at day 50 or 70. Heat exposure for 1 minute resulted in a log
reduction of 0.48 at 70°C and increased with higher temperatures to 3.67 at 95°C. Although HEV infectivity titration
by inoculation of the liver suspension onto three cell lines did not succeed, the results of the RNase-based method
are in accordance with published cell culture-based data.
Conclusions: Measurement of intact viral particles using the RNase-based method may provide data on the
stability of RNA viruses when cell culture-based infectivity titrations are not efficient or not available. The method
enables processing of large sample numbers and may be suitable to estimate stability of HEV in different types of
food.
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Background
The hepatitis E virus (HEV) is classified as the only
member of the genus Hepevirus, which is subdivided
into four genotypes (GT) and the avian HEV strains.
Recently, a novel hepatitis E-like virus has been detected
in faeces of wild rats [1]. HEV is a non-enveloped icosa-
hedral sphere of about 27 to 34 nm in diameter. Its gen-
ome consists of positive-sense single-stranded RNA of
about 7.2 kb in length and contains three open reading
frames (ORFs) [2-4]. ORF2 encodes the only capsid pro-
tein, forming the virus particle, whose atomic structure
has been solved recently [5].
HEV is one of the leading causes of human acute viral
hepatitis in Asia, the Middle East and Africa. In indus-
trialized countries, this virus has recently been recog-
nized as a pathogen of emerging concern [3,6]. Hepatitis
E is characterized by a self-limiting jaundice of varying
severity, which is hard to distinguish from other viral
hepatitis infections and is often accompanied by unspe-
cific symptoms like fever, headache and pain of the
upper abdomen. Although the case-fatality rate of hepa-
titis E is low in the general population (0.5 to 3%), rates
of up to 20% have been observed for pregnant women
[7-9]. HEV is mainly transmitted via the faecal-oral
route by contaminated drinking water or food. However,
in industrialized countries, zoonotic transmission is sus-
pected to be responsible for the increasing number of
autochthonous cases, with wild boars and pigs regarded
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hepatitis E cases after consumption of uncooked meat
from wild boar or deer strengthened the hypothesis of a
zoonotic transmission [14-16]. Recently, the consump-
tion of wild boar meat has been identified as one risk
factor for autochthonous HEV infections [6,9].
Only limited information is available about the heat
stability of HEV, mainly due to the lack of an efficient,
rapid and sensitive cell culture system. For all of the tis-
sue culture systems for HEV published so far, a rela-
tively high amount of virus is needed for successful
infection, virus replication proceeds slowly and cyto-
pathic effects are only rarely visible [4,17-19]. A first
study showed that infection of A549 cells was prevented
by heating of an HEV-containing cell suspension at 56°
C for 30 minutes [20]. Using HepG2/C3A cells and an
immunofluorescence assay for quantification of infective
viruses, the thermal stability of HEV GT1 and GT2
strains was investigated in more detail: GT1 was nearly
completely inactivated at temperatures between 56°C
and 60°C for one hour, whereas GT2 turned out to be
more resistant since only about 80% was inactivated at
60°C after one hour [21]. Time-course analyses showed
that about 95% of GT1 was inactivated within the first
15 minutes at 56°C although remaining infectious virus
was still detectable after one hour at this temperature
[21]. Another study using PLC/PRF/5 cells showed that
heating of a GT3-containing stool sample at 25°C or at
56°C for 30 minutes did not influence the infectivity in
opposite to heating at 70°C or 95°C for ten minutes. At
95°C even one minute was sufficient to prevent the
growth of the virus [19]. By monitoring of seroconver-
sion of pigs experimentally inoculated with an HEV
GT3-containing liver suspension it was shown that incu-
bation at 56°C for one hour did not affect infectivity,
whereas the suspension was no longer infective after
heating at 191°C (internal temperature of 71°C) or
above 100°C each for five minutes [22]. Yunoki et al.
showed that proteins or magnesium may act as stabili-
zers, which can increase heat stability of HEV [23].
The objective of this study was to gain more detailed
data about heat stability of HEV with regard to the
kinetics of inactivation, the temperatures needed for
complete inactivation and the influence of long-term
storage at different temperatures. A wild boar liver sus-
pension containing well characterized HEV GT3 [13]
was selected for the experiments because of the men-
tioned assumptions about HEV transmission via wild
boar meat to humans. Due to the challenges associated
with an efficient cell culture system, a molecular biologi-
cal approach was implemented. This approach employs
an RNase treatment of the heated samples to remove
any viral RNA released from disintegrated particles fol-
lowed by quantification of the remaining RNA using
real-time RT-PCR. Similar methods have been already
published for differentiation between intact and disinte-
grated particles of hepatitis A virus, poliovirus, feline
calicivirus and norovirus [24,25]. The novel approach
may be suitable for application of larger sample num-
bers, e.g. to estimate the stability of HEV in different
types of food, which is needed for further risk assess-
ment of HEV transmission by food.
Methods
Viral stock preparation
A wild boar liver containing the genotype 3i HEV isolate
wbGER27 [13], which had previously been shown to be
closely related to an HEV isolate from a human hepatitis
E case, was used in all experiments. The liver was thor-
oughly grinded in a mortar together with sterile sea
sand and phosphate buffered saline (PBS, pH 7.4). After
centrifugation at 3, 000 × g for 15 minutes, the superna-
tant was filtered through 0.2 μm and aliquots of the
liver suspension were stored at -80°C until use. Analysis
by quantitative real-time RT-PCR (see below) revealed 5
×1 0
8 genome equivalents (GE) per ml in the liver sus-
pension. Treatment with RNase A (see below) prior to
RNA extraction resulted in 3 × 10
7 GE/ml correspond-
ing to intact viral particles in the liver suspension.
Exposure of the virus suspension to different
temperatures
The liver suspension was thawed at room temperature
and 100 μl aliquots were transferred to 1.5 ml Eppen-
dorf-tubes, which were subsequently incubated in a
heating block (Thermomixer comfort, Eppendorf, Ham-
burg, Germany) at temperatures between 56°C and 95°C
for different time periods. For incubation at 4°C the ali-
quots were stored in the fridge (Liebherr, Ochsenhau-
sen, Germany). A temperature of 37°C was ensured in
an incubator (WTB Binder, Tuttlingen, Germany), while
other aliquots were stored on the bench at room tem-
perature (22°C). At each time-point, three replicates
were removed and immediately frozen at -80°C. Aliquots
frozen immediately without any RNase treatment and
aliquots treated with RNase A but without previous heat
treatment served as controls; water was used as negative
control.
RNase treatment and nucleic acid extraction
The RNase treatment is based on a protocol originally
developed for noroviruses by Mormann et al., 2010 [24].
Briefly, 3.5 μl of RNase A (7000 units/ml, Qiagen, Hil-
den, Germany) diluted 1:10 with nuclease-free water
was added to each sample and incubated at 37°C for
one hour resulting in the degradation of free RNA
released from disassembled viral particles during heat
treatment. Thereafter, RNase A activity was inhibited by
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(Qiagen, Hilden, Germany) followed by an incubation at
room temperature for 30 minutes. The RNA of the sam-
ple was isolated using the QIAamp Viral RNA Mini Kit
(Qiagen, Hilden, Germany) according to the manufac-
turer’s instructions. Finally, 50 units of Protector RNase
Inhibitor (Roche Diagnostics, Mannheim, Germany) were
added to the isolated RNA before an additional incuba-
tion step at room temperature for 30 minutes was
applied. After this procedure, no residual RNase activity
was detectable by the RNaseAlert Lab Test Kit (Applied
Biosystems, Darmstadt, Germany). The isolated RNA was
stored at -80°C until real-time RT-PCR analysis. After
each experiment, the bench and the pipettes were thor-
oughly cleaned using RNase AWAY (Carl Roth, Karls-
ruhe, Germany) in order to eliminate any residual RNase.
Quantitative real-time RT-PCR
For quantification of HEV RNA, in vitro transcribed
RNA standards were prepared for generation of an
external standard curve. Briefly, the complete region of
ORF3, which partially overlaps with ORF2, was ampli-
fied by RT-PCR from the liver suspension using primers
5’-AGC GTC TAG AAT GAA TAA CAT GTY YTG
TGC-3’ and 5’-GAC ATC TAG ATC AAC GGC GCA
GCC CCA GCT-3’ and subsequently cloned into the
vector pCR4 TOPO (Invitrogen, Karlsruhe, Germany).
This vector contains M13 priming sites before and after
a T7 promoter site attached to the insert. After confir-
mation of the sequence of the insert by DNA sequen-
cing, a fragment containing the T7 promoter together
with the ORF3 sequence was amplified by PCR with the
universal M13 primers and the TaKaRa Ex Taq (Takara
Bio Europe S.A.S., Saint-Germain-en-Laye, France). The
resulting PCR product of 534 bp was purified using the
QIAquick Gel Extraction Kit (Qiagen, Hilden, Ger-
many). In vitro transcription was performed from the
purified PCR product using the T7 MEGAscript Kit
(Applied Biosystems, Darmstadt, Germany) according to
the manufacturer’s instructions. Thereafter, residual
DNA was removed by the addition of 4 units TURBO™
DNase (Applied Biosystems, Darmstadt, Germany) fol-
lowed by an incubation at 37°C for 30 minutes. The
High Pure RNA Isolation Kit (Roche Diagnostics, Man-
nheim, Germany) was used for purification of the in
vitro transcribed RNA essentially as recommended by
the manufacturer; however, DNase I was not diluted
before use. The absence of residual DNA was confirmed
by a real-time PCR as described below, but by omitting
reverse transcription. RNA was quantified by photo-
metric measurement using the NanoDrop 1000 (Thermo
Scientific, Wilmington, USA) and molecule numbers
were calculated according to Fronhoffs et al., 2002 [26].
The real-time RT-PCR targeting a region of the ORF2/
ORF3 junction of the HEV genome was performed as
previously described [27] using the QuantiTect Probe
RT-PCR Kit (Qiagen, Hilden, Germany). Briefly, the reac-
tion mixture contains 10 μl of 2 × QuantiTect Probe RT-
PCR Master Mix, 0.2 μlo fE n z y m eR T - M i x ,t h ep r i m e r s
JVHEVF (5’-GGTGGTTTCTGGGGTGAC-3’)a n d
JVHEVR (5’-AGGGGTTGGTTGGATGAA-3’)i naf i n a l
concentration of 500 nM and the probe JVHEVP (5’-
FAM-TGATTCTCAGCCCTTCGC-BHQ-3’)i naf i n a l
concentration of 100 nM filled up with nuclease-free
water to a volume of 15 μl. Five μl of the sample or the
RNA standards were added to the reaction mixture to a
final volume of 20 μl. The reverse transcription pro-
ceeded at 50°C for 30 minutes, before an initial incuba-
tion at 95°C for 15 minutes followed by 45 cycles at 94°C
for ten seconds, at 55°C for 20 seconds and at 72°C for
one minute in an ABI PRISM 7500 cycler (Applied Bio-
systems, Foster City, USA). The threshold cycle (CT) was
automatically calculated byt h e7 5 0 0S o f t w a r eV e r s i o n
2.0.1 (Applied Biosystems, Foster City, USA).
Data analysis and statistics
The CT values of the tenfold serial dilutions from the in
vitro transcribed RNA stock solution were determined
and an external standard curve was generated by plot-
ting the logarithmic concentration against these CT
values. Each sample was analysed in triplicate. Linear
regression analysis was then used for calculation of the
number of GE present in the samples. Results desig-
nated as “undetermined” by the 7500 Software Version
2.0.1 (Applied Biosystems, Foster City, USA) were set
equal to the detection limit of the PCR so that the log
concentrations could be averaged and the standard
deviation (SD) could be calculated. Descriptive statistical
parameters (average, SD, 95%-confidence intervals) were
calculated using Microsoft Excel 2003. The log reduc-
tion rate was defined as the logarithm of the quotient of
the GE number of the heat treated sample and the GE
number of the aliquot without previous heat treatment.
The GE number of the liver sample without heat treat-
ment was set as 100% for calculation of the inactivation
rate expressed in percent. The data obtained from the
long-term storage experiments were further analysed
using the “Geeraerd and Van Impe Inactivation Model
Fitting Tool” (GInaFiT) for Microsoft Excel [28] in
order to fit a mathematic model to the data.
Cell culture and immunofluorescence
Attempts to titrate infectious HEV were undertaken by
inoculation of the liver homogenate preparations on the
cell lines PLC/PRF/5, A549 and HepG2 followed by
viral antigen detection by immunofluorescence. The cell
lines were chosen according to published protocols for
propagation of HEV [4,19-21]. All cell lines were grown
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(FBS), 1% L-glutamine, 1% non-essential amino acids
and 0.5% gentamycine at 37°C and 5% CO2 atmosphere.
The cell cultures were seeded on Lab-Tek glass chamber
slides (Nalge Nunc International, Rochester, USA) and
grown until 80% confluence. For infection, 100 μlo ft h e
wild boar liver suspension were inoculated onto the
cells and incubated for one hour at room temperature.
Thereafter, the virus suspension was replaced by med-
ium without antibiotics and FBS and incubated at 34.5°
C. After 24 h the supernatant was removed, medium
containing antibiotics and 5% FBS was added and incu-
bated for additional 5 days at 34.5°C. Thereafter, the
cells were washed with PBS, fixed with acetone/metha-
nol (1:1 v/v) at -20°C for 30 minutes and dried. A pig
serum previously shown to contain HEV-GT3-specific
antibodies using three different serological assays [10]
w a sa d d e da ta1 : 1 0 0d i l u t i o ni nP B Sa n di n c u b a t e da t
37°C for one hour. After three washings with PBS, the
secondary antibody FITC-conjugated anti-pig IgG
(Sigma, Deisenhofen, Germany) was added at a 1:500
dilution and incubated at 37°C for 30 min. The slides
were rinsed two times in PBS and one time in distilled
water, dried and fluorescent cells were analyzed in a
fluorescence microscope.
Results
Establishment of a quantitative real-time RT-PCR for HEV
For quantification of the HEV genome, RNA standards
were constructed. After cloning of the complete HEV
ORF3 into the vector pCR4 TOPO (Invitrogen, Karlsruhe,
Germany), the insert was amplified by PCR with the uni-
versal M13 primers, purified and used for in vitro tran-
scription. The resulting RNA concentration was
determined to be 367.3 ng/μlw i t ha nO D 260/280 ratio of
2.06 and an OD260/230 ratio of 2.31 indicating high purity
of the RNA. The absence of residual DNA was confirmed
by a real-time PCR without reverse transcription, which
showed a negative PCR result. A linear correlation
between CT values and the logarithmic concentration of
serial dilutions of in vitro transcribed RNA was evident in
the range between 66 and 6.6 × 10
9 GE per PCR assay,
with a slope of -3.7 and a regression coefficient (R
2)o f
0.9968. The limit of detection of this real-time RT-PCR as
determined by dilution series of the in vitro transcribed
RNA was seven GE per PCR assay. Analysis of RNA iso-
lated from the wild boar liver suspension used in the fol-
lowing experiments by the quantitative real-time RT-PCR
revealed a concentration of 5 × 10
8 HEV GE per ml.
Implementation of an RNase-based assay for measuring
capsid-protected RNA
PCR based methods are generally not suitable for differ-
entiation between infectious and non-infectious viruses.
The addition of an RNase may enable the differentiation
between intact and disintegrated viral particles. The
activity of the RNase, however, has to be inhibited
before RNA extraction is performed and a final addition
of a second RNase inhibitor should avoid any further
RNA degradation after RNA isolation. For an overview
of the applied procedure see Figure 1. In control experi-
ments, 100 μl of in vitro transcribed RNA dilutions con-
taining up to 1.3 × 10
7 GE or 100 μlo ft h ew i l db o a r
liver suspension previously heated at 90°C for 30 min-
utes were subjected to the RNase treatment procedure.
By a following real-time RT-PCR, no signal was detect-
able in these cases indicating that concentration and
incubation conditions of the RNase A are sufficient to
eliminate any free HEV-specific RNA present in the
sample. In order to exclude a further RNA degradation
after nucleic acid extraction, aliquots of the extracted
RNA were tested by the RNaseAlert Lab Test Kit
(Applied Biosystems, Darmstadt, Germany) demonstrat-
ing that no RNase activity was detectable. By application
of the whole procedure to the wild boar liver suspension
Heat treatment of sample
RNase treatment
(RNase A, 1 h at 37°C)
RNase inhibition I
(Qiagen RNase Inhibitor,
22°C for 30 min)
RNA extraction
Real-time RT-PCR
RNase inhibition II 
(Protector RNase Inhibitor,
22°C for 30 min)
Figure 1 Procedure of RNase treatment. Schematic presentation
of the procedure used for determination of heat stability of HEV
using a quantitative detection method for capsid-protected RNA.
After initial RNase treatment, the sample is subjected to two steps
of RNase inhibition in order to remove any residual RNase activity.
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×1 0
7 RNase-protected HEV GE per ml was determined.
Inactivation by short-term heating
In order to enable comparison with published studies
using tissue culture methods, the effect of short term
heating on HEV was analysed at previously used tem-
perature/time combinations. After an incubation at 56°C
for 15 minutes, the amount of RNase-protected HEV
RNA decreased remarkably as compared to the
untreated control, with a reduction rate of 74.07% (-0.59
log10). The incubation of HEV at 56°C for 30 or 60 min-
utes, or at 60°C for 15 minutes, 30 minutes or 60 min-
utes led to reduction rates above 99% (-2.16 to -4.42
log10). These results are presented in Table 1 together
with results of published cell culture-based studies.
Incubation at 60°C for 90 minutes resulted in no detect-
able RNA (not shown).
Effect of long-term storage at different temperatures
The influence of long-term storage conditions on the
stability of HEV was tested by incubation of 100 μl ali-
quots of the liver suspension at 4°C, 22°C and 37°C.
Protected HEV RNA was detectable at 22°C and 37°C as
long as 50 days and at 4°C as long as 70 days, i.e. for
the entire period of the experiments. The data of these
inactivation trials could be fitted best by the biphasic
model according to Cerf (1977) using GInaFiT for
Microsoft Excel [28,29] (Figure 2A-C). As characteristic
of this model, first a decrease of the intact viruses could
be observed until a stationary phase is reached. For
determination of the time-point of the change to the
stationary phase the log concentrations of the last three
data points were used to calculate the average stationary
phase log concentration level. The associated 95%-confi-
dence interval was then applied to classify the preceding
measurements as “belonging” or “not belonging” to the
stationary phase. If further data points had to be inte-
grated into the calculation of the stationary phase aver-
age, the procedure was repeated until the first data
point “not belonging” to the stationary phase was
reached. Based on these calculations, the stationary
phase is reached after one hour at 4°C resulting in a
0.34 log10 reduction and after three days at 22°C result-
ing in a 0.45 log10 reduction. At 37°C, the maximum
reduction of 1.24 log10 was reached after seven days.
Assessment of HEV stability at different temperatures for
one minute
The liver suspension (100 μl) was incubated at 70°C, 75°
C, 80°C, 85°C, 90°C and 95°C each for one minute in tri-
plicate (Figure 3). The exposure of HEV to 70°C for one
minute led to an average log reduction of protected
RNA of 0.48. At 75°C the reduction rate slightly
increased (-0.72 log10). Incubation at 80°C and 85°C for
one minute resulted in a 2.47-log10 and in a 2.58-log10
reduction, respectively, whereas the incubation at 90°C
for one minute led to a 3.58-log10 reduction. Finally, the
exposure of HEV to 95°C for one minute resulted in a
log reduction of 3.67. The higher variability of the deter-
m i n e dv a l u e sa tt e m p e r a t u r e sh i g h e rt h a n7 5 ° Ca s
reflected by the high standard deviations (see Figure 3)
coincided with the appearance of insoluble material pre-
cipitating from the organ suspensions at these
temperatures.
Inoculation of the virus preparation on cell cultures
In order to titrate infectivity of the virus preparation
used in the RNase-based assay, attempts were underta-
ken to demonstrate virus infection in cell cultures.
Three types of monolayer cell cultures were inoculated
with the liver suspension and the presence of viral anti-
gen in the cells was analyzed by immunofluorescence at
6 days after inoculation. For PLC/PRF/5 cells, fluores-
cence could not be quantified due to extensive back-
ground staining as assessed by comparison with a
negative control. In HepG2 cells and in A549 cells, iso-
lated cells with a stronger staining than observed in the
negative control could be detected in the slides inocu-
lated with the native liver suspension (not shown). How-
ever, the number of stained cells varied remarkably and
fluorescent cells were not detected in all replicates
inoculated with this preparation. A long-term infection
trial was performed by inoculation of the native liver
suspension onto the three cell lines followed by incuba-
tion at 34.5°C for 30 days. Testing of aliquots of the
Table 1 Comparison of data generated in this study and those published by other studies for HEV inactivation.
Inactivation (tissue culture assay) Reduction (RNase protection assay)
Temperature Time Huang et al., 1999 [20] Emerson et al., 2005 [21] Tanaka et al., 2007 [19] This study
GT1 GT1 GT2 GT3 GT3
56°C 15 min ND 95% ND ND 74.07%
56°C 30 min inactivated 99% ND not inactivated 99.99%
56°C 60 min ND 99% not inactivated ND 99.90%
60°C 60 min ND 96% 80% ND 99.94%
95°C 1 min ND ND ND inactivated 99.98%
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constantly decreasing amounts of the HEV genome over
the whole duration of the experiment (data not shown).
Discussion
The increasing number of recorded hepatitis E cases led
to the recognition of HEV as an emerging pathogen in
industrialized countries [30]. Since many of these infec-
tions cannot be explained by importation of HEV infec-
tions from endemic regions, attention has been drawn
to alternative routes of transmission. Due to the detec-
tion of HEV strains closely related to human HEV in
wild boars and pigs, these animals are regarded as reser-
voirs of this virus [13,31,32]. By a case control study
performed in Germany and by investigations on food-
borne hepatitis E outbreaks in Japan, a transmission
route via the consumption of wild boar meat is sup-
ported [9,14,15,33,34]. In order to provide guidelines for
prevention of such food-borne transmissions, studies
determining inactivation kinetics of HEV exposed to
heating and long-term storage are currently needed.
Most of the previous studies assessing thermal stability
of HEV are based on different cell culture systems for
the detection of infectious HEV particles [19-21,23]; and
one study used a swine bioassay [22]. Because the used
cell culture techniques and animal experiments are
sophisticated, time-consuming and relay on special facil-
ities, studies with larger sample numbers could not be
performed and only some selected temperature/time
combinations have been tested so far. Isolation and pro-
pagation of HEV in tissue culture is difficult and depen-
dent on the amount of virus used for inoculation
[4,19,35]. Very recently, an HEV variant, which showed
a more rapid growth in cell culture, has been isolated
from a chronically infected patient [36]; however, the
significance of this finding has to be investigated further.
In almost all studies performing animal experiments,
pigs are infected intravenously with HEV although this
kind of inoculation does not reflect the natural route of
transmission. However, pigs infected orally with HEV
need larger virus amounts [37-39]. Therefore, low
amounts of infectious virus present in the sample after
heat inactivation may not be detected using these test
systems. As no reliable cultivable surrogate for HEV is
known until now, other techniques may help to estimate
heat stability of this virus.
Recently, a molecular biological approach has been
applied successfully for the assessment of the stability of
noroviruses during technical processes [24]. Similar
approaches have been used for stability studies with
hepatitis A virus, poliovirus type 1 and feline calicivirus
[25,40]. In these approaches, remaining ‘intact’ viral
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Figure 2 Effect of long-term storage at different temperatures
on HEV stability. An HEV-containing liver suspension was
incubated at 4°C (A), 22°C (B) or 37°C (C) for up to 70 days and
protected RNA was quantified using real-time RT-PCR. The resulting
data were used for fitting of a curve using a biphasic model
according to Cerf, 1977 (29).
Schielke et al. Virology Journal 2011, 8:487
http://www.virologyj.com/content/8/1/487
Page 6 of 9particles present after treatment are identified by their
ability to protect the viral RNA genome from degrada-
tion. Although these ‘intact’ viruses are per se not neces-
sarily infectious, a direct correlation between detection
of protected RNA and detection of cell-culture infec-
tious virus has been described [41]. The major advan-
tage of this molecular biological method is that it can be
implemented by any laboratory proficient in molecular
biological techniques and that several temperature/time
combinations can be tested. This is especially important
when information about the stability of food- or water-
borne pathogens is limited and an efficient cell culture
method or animal model does not exist. The described
method may also be relevant for routine safety controls
of suspicious foods, whereas cell culture-based methods
may not be applicable for routine diagnostic. For risk
assessment analyses it might be advantageous that mole-
cular biological techniques tend to overestimate the sta-
bility of the viruses since all particles are detected,
which protect the viral RNA from degradation, even if
these particles may no longer be infectious due to con-
formational changes on the surface of the capsid pro-
tein, whereas an underestimation of the viral load may
have serious consequences.
The molecular biological method described here was
attempted to be validated by using cell culture systems
described earlier [4,19-21]. However, although some
fluorescent cells were detected at 6 days after
inoculation of the native liver suspension, a quantifica-
tion of infectious HEV particles in the preparation and a
convincing demonstration of virus replication in the cell
cultures were not possible. The distinct reasons for
these findings are not known, but as already described,
propagation of HEV in cell culture is difficult and relies
on a number of prerequisites, which may have missed in
these experiments. First, all of the described successful
propagation trials of HEV in cell cultures were per-
formed with inocula containing very high HEV titres
[4,19-21]. The amount of infectious HEV present in our
sample might be too low. Second, only inoculation of
serum and faecal samples in cell cultures has been
described to result in successfully HEV propagation so
far [4,17-19]. It might be speculated that preparations of
liver tissue contain only a low proportion of HEV which
is able to infect cell cultures. Third, it is not known if
the distinct HEV strain present in our liver suspension
is capable of efficient propagation in the used cell lines.
T h eu s e ds t r a i nw a so ft h eG T 3s u b t y p ei[ 1 3 ] ,f o r
which propagation in cell cultures has not been
described so far.
As a direct validation of our results using cell culture
experiments could not be done, we used published data
on HEV stability derived from cell culture experiments
and experimental animal inoculations for comparison.
As shown in Table 1, the results of our study using the
molecular biological approach are generally in
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Page 7 of 9accordance with that of the published studies. For exam-
ple, inactivation rates between 99% and 100% have been
reported for HEV after incubation at 56°C for 30 min-
utes [20,21]. Using the same conditions, we determined
a reduction rate of 99.99% (-4.42 log10). Heating of HEV
at 56°C for 15 minutes resulted in an inactivation rate
of 95% [21], which is comparable with the reduction
rate of 74% (-0.59 log10) determined in our approach. At
60°C for one hour, inactivation rates of 96% and 80%
were described for HEV GT1 and GT2, respectively
[21], whereas in our experiments, 99.94% (-3.25 log10)o f
HEV GT3 was inactivated under these conditions. It is
also evident from this comparison, that additional fac-
tors like the used genotype, the used virus amount and
the type of cell cultures may further influence the result.
The data of our long-term storage trials generated
with the molecular biological approach could be fitted
b e s tb yab i p h a s i cm o d e la c c o r d i n gt oC e r f ,1 9 7 7
[28,29]. The major characteristics of this model are an
initial decrease of intact viruses followed by a stationary
phase, where the virus is inactivated only very slowly.
The same model has been successfully applied pre-
viously for inactivation curves of foot-and-mouth disease
viruses [42]. Generally, relative low reduction rates were
recorded for HEV at 4°C, 22°C and 37°C, indicating that
HEV is able to survive for a long time in the environ-
ment. The maximum reduction of 1.24 log10 was
reached after seven days at 37°C. Thereafter, the viral
load remained constant for several weeks on a relatively
high level. Similar inactivation curves showing a tailing
in the logarithmic plot were reported for murine noro-
virus, feline calicivirus and poliovirus exposed to differ-
ent temperature and pressure conditions [43-45]. Since
an adaptation of the viruses to the different environ-
mental conditions is not possible, the stationary phase
may reflect the heterogeneous sensitivities of the virus
particles to different temperatures [43].
For short-term heating, our data show that exposure
of HEV to 70°C for one minute resulted only in a log
reduction of 0.48. According to Koopmans and Duizer
(2004), the risk of infection for the consumer after cook-
ing contaminated meat could be categorized as low or
negligible by a log reduction of 3 or 4, respectively [46].
Based on our data, a log reduction of 3 could be only
achieved after heating at 90°C for one minute, and incu-
bation at 95°C for one minute was necessary for a log
reduction of about 4.
Conclusions
In summary, this study provides novel data on the ther-
mal stability of HEV using a molecular biological
approach, which is able to differentiate between intact
and disintegrated virus particles. Although these data
show that HEV is considerable sensitive to heat, residual
infectious virus has to be expected after most short-
term heating procedures of meat, which may explain the
documented cases of hepatitis E after consumption of
grilled wild boar meat [14-16]. Other temperature/time
combinations may be tested in further studies in order
to provide a safe procedure for preparation of meat
without the risk of HEV infection. As the type of food
and its specific processing may also influence the stabi-
lity of HEV, many different parameters have to be
tested, which may be more easily analysed using the
molecular biological approach.
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